Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor.

Abstract

These findings indicate that fasudil might have a therapeutic potential for ocular angiogenic diseases. The antiangiogenic effect of fasudil appears to be mediated through the blockade not only of Rho-kinase signaling but also of ERK and Akt signaling.